Stock page
BioVentrix Inc (BVXX)
BioVentrix Inc is a clinical stage medical device company focused on developing, manufacturing and commercializing proprietary devices to restore left ventricular function in heart failure patients with reduced ejection fraction (HFrEF). Its flagship product, the Revivent System, is designed to enable a less invasive procedure for patients with ischemic heart failure with reduced ejection fraction and a dilated left ventricle. Its offering also includes Alginate, a hydrogel-based device treatment for HFrEF patients without anterior scarring.
Quote snapshot
$0.00
Daily change: —
ExchangeNAS
Updated2026-05-09T04:33:39.954058Z
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|